Observational studyJournal of managed care & specialty pharmacy2026

Real-world treatment patterns, resource use, and costs in human epidermal growth factor receptor 2-negative advanced gastric/gastroesophageal junction cancer in the United States in the immune checkpoint inhibitor era.

Ziyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.